Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ (4,162)	$ 45,714
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	513	286
Loss on disposal of property and equipment	33
Share-based compensation expense	8,385	7,131
Change in fair value of note hedge warrants		(19)
Non-cash interest expense	589	402
Deferred income taxes	6,050	17,052
Changes in assets and liabilities:
Accounts receivable, net	57,107	14,298
Prepaid expenses and other current assets	(2,607)	(3,669)
Operating lease right-of-use assets	378	349
Other assets	30	27
Accounts payable and accrued expenses	(12,526)	705
Accrued research and development costs	(9,451)	(2,384)
Operating lease liabilities	(523)	(479)
Other liabilities	1,169	758
Net cash provided by operating activities	44,985	80,171
Cash flows from investing activities:
Purchases of property and equipment	(68)	(13)
Net cash used in investing activities	(68)	(13)
Cash flows from financing activities:
Proceeds from exercise of stock options and employee stock purchase plan	10,061	3,981
Taxes paid related to net share settlement of share-based awards	(616)
Repayments of revolving credit facility	(25,000)
Net cash provided by (used in) financing activities	(15,555)	3,981
Effect of exchange rate changes on cash, cash equivalents and restricted cash	24
Net increase in cash, cash equivalents and restricted cash	29,386	84,139
Cash, cash equivalents and restricted cash, beginning of period	92,154	657,938
Cash, cash equivalents and restricted cash, end of period	$ 121,540	$ 742,077